Publications by authors named "Ya-wei Zou"

Background: The typical manifestations of Penicillium marneffei (nowadays Talaromyces marneffei) infection in children without human immunodeficiency virus (HIV) remain unclear. The current work presents the case of a child without an underlying disease who was infected with P. marneffei comorbid with eosinophilia.

View Article and Find Full Text PDF

The aim of study was to investigate the effect of acute lymphoblastic leukemia (ALL) children bone marrow mesenchymal stem cells (MSC) on resistance of K562/A02 cells and its mechanism. MSC obtained from bone marrow of AL children were cultured and identified. The co-culture of MSC and K562/A02 and the culture of K562/A02 cell suspension alone was performed, of which 2 kinds of cells were treated with same concentration of adriamycin (ADM), and the rate of apoptosis was detected by flow cytometry, bcl-2 and bax of K562/A02 were detected by RT-PCR, while mdr1 gene level was detected by FQ-PCR.

View Article and Find Full Text PDF

Objective: To investigate the safety and therapeutic effect of low dose (1000 U/m(2)) L-asparaginase (L-Asp) in the treatment of children with acute lymphoblastic leukemia (ALL).

Methods: Six patients were treated with low dose L-Asp after previously suffered severe side effects from standard dose L-Asp (5000 - 10,000 U/m(2)). Twenty-eight blood samples were obtained randomly from 5 of them.

View Article and Find Full Text PDF

Primer Express 2.0 software was used to design the primers and the MGB probe. With the plasmid pHaMDR1/A containing mdr1 cDNA as the template, we established a real-time fluorescent quantitative polymerase chain reaction system, which, at the template concentration of 3.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the effectiveness of E. coli asparaginase (L-asp) in reducing asparagines (ASN) levels in children with acute lymphoblastic leukemia (ALL) during chemotherapy.
  • Data were collected from 15 children receiving a specific regimen of L-asp, showing that plasma L-asp activity increased after multiple doses while ASN levels significantly decreased.
  • The findings suggest that the current treatment protocol effectively maintains low ASN levels, which is beneficial for treating ALL in children.
View Article and Find Full Text PDF